Participating in the launch of «Takeda» production line for the Ixazomib in Yaroslavl
On August 1, 2018, Vladislav Shestakov, Director of the FSI “SID and GP”, took part in the opening ceremony at the for the production line for the Ixazomib, an innovative medicine for patients with multiple myeloma. The ceremony was held in Yaroslavl plant of «Takeda Pharmaceuticals». The total investment in the Russian production of the medicine amounted to 477 million rubles.
The solemn opening ceremony also saw the attendance: Governor of Yaroslavl region – Dmitry Mironov; Head of the Department of Pharmaceutical and Medical Industry Development of Minpromtorg Russia – Aleksey Alekhin; Director of the Europe Department of the Ministry of Foreign Affairs of Japan – Yasushi Masaki; Representative of the Yaroslavl region in the Federation Council – Igor Kagramanyan; CEO of the “Takeda Russia”, the Head of the CIS – Andrey Potapov; Director of the “Takeda Yaroslavl” Macey Fabiancic.
- Russia will be able to join PIC/S and break into new pharmaceutical markets
- Mutual trust is the fundamental principle of building relationships between the EAEU member countries
- «SID & GP» specialists held the advanced training course at the premises of SPbSRIVS
- Director of the SID & GP dispels myths about Russian medicines
- Try on the role of the GMP-inspector